Company News 24 Feb 2026 Half-Year Financial Report – period to 31 December 2025 Orthocell has released its half-year financial report for the six months to 31 December 2025, reflecting strong operational progress and continued execution of its global… Orthocell
Company News 18 Feb 2026 Orthocell receives $3.0m R&D tax incentive refund Orthocell has received a Research and Development (R&D) Tax Incentive refund of A$3.0 million for the financial year ended 30… Orthocell
Company News, Video 02 Feb 2026 February 2026 Orthocell Investor Webinar Replay  In this webinar, Orthocell Chair, John Van Der Wielen, CEO and MD, Paul Anderson, and Independent Director, Dr Ravi Thadani provide an important operational update… Orthocell
